Management of variceal hemorrhage: Defining portal hypertension

Current Problems in Surgery

Volumn 40, Issue 6, 2003, Pages 263-343

  Rosemurgy, Alexander S ^a   Zervos, Emmanuel E ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN DERIVATIVE; VASOPRESSIN;

BLOOD COMPONENT THERAPY; DECOMPRESSION SURGERY; DEVASCULARIZATION; DISEASE CLASSIFICATION; END TO SIDE ANASTOMOSIS; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; LONG TERM CARE; MESENTERIOCAVAL ANASTOMOSIS; PORTAL HYPERTENSION; PORTOCAVAL SHUNT; PORTOSYSTEMIC ANASTOMOSIS; RESUSCITATION; REVIEW; RISK ASSESSMENT; SIDE TO SIDE ANASTOMOSIS; SPLENORENAL SHUNT; TREATMENT PLANNING; ADULT; AGED; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; COMPARATIVE STUDY; ESOPHAGOSCOPY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BALLOON OCCLUSION; EMBOLIZATION, THERAPEUTIC; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMANS; HYPERTENSION, PORTAL; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0038680643     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Simert G, Persson T, Vang J. Factors predicting survival after portacaval shunt: a multiple linear regression analysis. Ann Surg 1978;187:174-8.
2. Wantz GE, PM. Experience with portacaval shunt for portal hypertension. N Engl J Med 1965;265:721.
3. Campbell DP, Parker DE, Anagnostopoulos CE. Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg 1973;126:748-51.
4. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-8.
5. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
6. Akahoshi T, et al. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002;131(1 Suppl):S176-81.
7. MacDougall BR, Westaby D, Theodossi A, et al. Increased long-term survival in variceal haemorrhage using injection sclerotherapy: results of a controlled trial. Lancet 1982;1:124-7.
8. Westaby D, Hayes PC, Gimson AE, et al. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989;9:274-7.
9. Rikkers LF, Jin G, Burnett DA, et al. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1993;165:27-32; discussion 32-3.
10. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.
11. Orloff MJ, Orloff MS, Girard B, et al. When is liver transplant indicated in cirrhosis with bleeding varices? Transplant Proc 2001;33:1366.
12. Brems JJ, Hiatt JR, Klein AS, et al. Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg 1989;209:51-6.
13. Sugiura M, Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg 1973;66:677-85.
14. Inokuchi K. Present status of surgical treatment of esophageal varices in Japan: a nationwide survey of 3,588 patients. World J Surg 1985;9:171-80.
15. Gouge TH, Ranson JH. Esophageal transection and paraesophagogastric devascularization for bleeding esophageal varices. Am J Surg 1986;151:47-54.
16. Weese JL, Starling JR, Yale CE. Control of bleeding esophageal varices by transabdominal esophageal transection, gastric devascularization, and splenectomy. Surg Gastroenterol 1984;3:31-6.
17. Barbot DJ, Rosato EF. Experience with the esophagogastric devascularization procedure. Surgery 1987;101:685-90.
18. Ginsberg RJ, Waters PF, Zeldin RA, et al. A modified Sugiura procedure. Ann Thorac Surg 1982;34:258-64.
19. Orozco H, et al. Elective treatment of bleeding varices with the Sugiura operation over 10 years. Am J Surg 1992;163:585-9.
20. Rikkers LF. The changing spectrum of treatment for variceal bleeding. Ann Surg 1998;228:536-46.
21. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
22. Paquet KJ, Lazar A, Koussouris P, et al. Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br J Surg 1995;82:199-203.
23. Mercado MA, Orozco H, Guillen-Navarro E, et al. Small-diameter mesocaval shunts: a 10-year evaluation. J Gastrointest Surg 2000;4:453-7.
24. Salam AA, Warren WD, Le Page JR, et al. Hemodynamic contrasts between selective and total portal-systemic decompression. Ann Surg 1971;173:827-44.
25. Rosenthal D, Barber WA, Lamis PA, et al. The jugular vein as an interposition graft in the distal splenorenal shunt. Surg Gynecol Obstet 1985;161:372-4.
26. Orloff MJ. Emergency shunt for variceal bleeding. J Am Coll Surg 1995;181:386-8.
27. Orloff MJ, Bell RH Jr. Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis. Am J Surg 1986;151:176-83.
28. Orloff MJ, Bell RH Jr, Orloff MS, et al. Emergency portacaval shunt: a perspective on the perspective. Hepatology 1995;21:1203-6.
29. Orloff MJ, Bell RH Jr, Orloff MS, et al. Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices. Hepatology 1994;20:863-72.
30. Orloff MJ, Orloff MS, Orloff SL, Girard B. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites. J Am Coll Surg 1997;184:557-70.
31. Orloff MJ, Orloff MS, Orloff SL, Haynes KS. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology 1995;21:1011-7.
32. Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995;180:257-72.
33. Orloff MJ, Orloff MS, Rambotti M. Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: results of portal-systemic shunts during 35 years. J Pediatr Surg 1994;29:142-51; discussion 151-4.
34. Orloff MJ, Orloff MS, Rambotti M, Girard B. Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 1992;216:256-66; discussion 266-8.
35. Villeneuve JP, Pomier-Layrangues G, Dugvay L, et al. Emergency portacaval shunt for variceal hemorrhage: a prospective study. Ann Surg 1987;206:48-52.
36. Planas R, Boix J, Broggi M, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1991;100:1078-86.
37. Rikkers LF. Portal hemodynamics, intestinal absorption, and postshunt encephalopathy. Surgery 1983;94:126-33.
38. Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-55.
39. Orozco H, Mercado MA. Devascularizations in portal hypertension. J Am Coll Surg 2002;194:247-9.
40. Warren WD, Henderson JM, Millikan WJ, et al. Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding: preliminary report of a prospective, randomized trial. Ann Surg 1986;203:454-62.
41. Iliopoulos JI, Thomas JH, Pierce GE, et al. Splenocaval shunt for selective portal decompression. World J Surg 1988;12:852-5.
42. Adson MA, van Heerden JA, Ilstrup DM. The distal splenorenal shunt. Arch Surg 1984;119:609-14.
43. Nordlinger BM, Nordlinger DF, Fulenwider JT, et al. Angiography in portal hypertension: clinical significance in surgery. Am J Surg 1980;139:132-41.
44. Busuttil RW, Brin B, Tompkins RK. Matched control study of distal splenorenal and portacaval shunts in the treatment of bleeding esophageal varices. Am J Surg 1979;138:62-7.
45. Grace ND, Conn HO, Resnick RH, et al. Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology 1988;8:1475-81.
46. Harley HA, Morgan T, Redeker AG, et al. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology 1986;91:802-9.
47. Langer B, et al. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt: an analysis of encephalopathy survival, and quality of life. Gastroenterology 1985;88:424-9.
48. Mitchell RL, Ignatius JA. Distal splenorenal shunt: standard procedure for elective and emergency treatment of bleeding esophageal varices. Am J Surg 1988;156: 169-72.
49. Orozco H, Juarez F, Santillan P, et al. Ten years of selective shunts for hemorrhagic portal hypertension. Surgery 1988;103:27-31.
50. Spina G, Santambrugio R, Opoches E, et al. Improved quality of life after distal splenorenal shunt: a prospective comparison with side-to-side portacaval shunt. Ann Surg 1988;208:104-9.
51. Spina GP, Galeotti F, Opoches E, et al. Selective distal splenorenal shunt versus side-to-side portacaval shunt: clinical results of a prospective, controlled study. Am J Surg 1988;155:564-71.
52. Rikkers LF, Rudman D, Galambos JT, et al. A randomized, controlled trial of the distal splenorenal shunt. Ann Surg 1978;188:271-82.
53. Warren WD, Milikan WJ Jr, Henderson JM, et al. Ten years portal hypertensive surgery at Emory: results and new perspectives. Ann Surg 1982;195:530-42.
54. Millikan WJ Jr, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg 1985;201:712-22.
55. Reichle FA, Fahmy WF, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg 1979;137:13-21.
56. Henderson JM, Millikan WJ Jr, Wright-Bacon L, et al. Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt: effect on survival? Ann Surg 1983;198:325-34.
57. Gordon MJ, Del Guercio LR. Late effects of portal systemic shunting procedures on cardio-respiratory dynamics in man. Ann Surg 1972;176:672-9.
58. Levi JU, Zeppa R, Hutson DG, et al. Early hemodynamic effects of the distal splenorenal shunt. Surg Forum 1976;27:370.
59. Widrich WC, et al. Long-term follow-up of distal splenorenal shunts: evaluation by arteriography, shuntography, transhepatic portal venography, and cinefluorography. Radiology 1980;134:341-5.
60. Koyanagi N, Iso Y, Higasni H, et al. Increased platelet count as a screening test for distal splenorenal shunt patency. Am J Surg 1988;156:29-33.
61. Henderson JM, Millikan WJ, Warren WD. Selective variceal decompression by the distal splenorenal shunt: an emory perspective twenty years later. Emory University J Med 1987;1:48-65.
62. Henderson JM, Millikan WJ Jr, Chipponi J, et al. The incidence and natural history of thrombus in the portal vein following distal splenorenal shunt. Ann Surg 1982;196:1-7.
63. Rotstein LE, et al. Thrombosis of the portal vein following distal splenorenal shunt. Surg Gynecol Obstet 1979;149:847-51.
64. Rikkers LF, Cormier RA, Vo NM. Effects of altered portal hemodynamics after distal splenorenal shunts. Am J Surg 1987;153:80-5.
65. Fischer JE, Bower RH, Atamian J, et al. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg 1981;194:531-44.
66. Mercado MA, et al. Distal splenorenal shunt versus 10-mm low-diameter mesocaval shunt for variceal hemorrhage. Am J Surg 1996;171:591-5.
67. Herz R, Halbfass HJ, Rossle M, et al. Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy. Klin Wochenschr 1985;63:409-18.
68. Vo NM, Rikkers LF. Hyperbilirubinemia following distal splenorenal shunt. Arch Surg 1985;120(3):301-5.
69. Reichle FA, Owen OE. Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts. Ann Surg 1979;190:523-34.
70. Mathie RT, Toouli J, Smith J, et al. Hepatic tissue perfusion studies during distal splenorenal shunt. Am J Surg 1980;140:384-6.
71. Maillard JN, Flamant YM, Hay JM, et al. Selectivity of the distal splenorenal shunt. Surgery 1979;86:663-71.
72. Belghiti J, Grenier P, Novel O, et al. Long-term loss of Warren's shunt selectivity. Angiographic demonstration. Arch Surg 1981;116:1121-4.
73. Rikkers LF. Is the distal splenorenal shunt better? Hepatology 1988;8:1705-7.
74. Henderson JM, Warren WD, Millikan WJ, et al. Distal splenorenal shunt with splenopancreatic disconnection. A 4-year assessment. Ann Surg 1989;210:332-9 discussion 339-41.
75. Henderson JM, Millikan WJ Jr, Galloway JR. The Emory perspective of the distal splenorenal shunt in 1990. Am J Surg 1990;160:54-9.
76. Vo NM, Rikkers LF. Splanchnic hemodynamic changes after the distal spleno renal shunt. Am Surg 1986;52:568-71.
77. Johansen K. Prospective comparison of partial versus total portal decompression for bleeding esophageal varices. Surg Gynecol Obstet 1992;175:528-34.
78. Reynolds JT. Portal hypertension; use of venous grafts when side to side anastamosis is impossible. Arch Surg 1951;62:789.
79. Adam R, Diamond T, Bismuth H. Partial portacaval shunt: renaissance of an old concept. Surgery 1992;111:610-6.
80. Sarfeh IJ, Carter JA, Welch HF. Analysis of operative mortality after portal decompressive procedures in cirrhotic patients. Am J Surg 1980;140:306-11.
81. Sarfeh IJ. Comparative study of portacaval and mesocaval interposition shunts. Am J Surg 1981;142:511-3.
82. Capussotti L, Vergara V, Polastri R, et al. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial. Surgery 2000;127:614-21.
83. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective, randomized clinical trial. Ann Surg 1994;219:353-61.
84. Johansen K. Partial portal decompression for variceal hemorrhage. Am J Surg 1989;157:479-82.
85. Capussotti L, Vergara V, Polastri R, et al. A critical appraisal of the small-diameter portacaval H-graft. Am J Surg 1995;170:10-14.
86. Collins JC, et al. Partial portacaval shunt for variceal hemorrhage: longitudinal analysis of effectiveness. Arch Surg 1998;133:590-2; discussion 592-4.
87. Rypins EB, Sarfeh IJ. Small-diameter portacaval H-graft for variceal hemorrhage. Surg Clin North Am 1990;70:395-404.
88. Sarfeh IJ, et al. Serial measurement of portal hemodynamics after partial portal decompression. Surgery 1986;100:52-8.
89. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters: clinical and hemodynamic perspectives. Ann Surg 1986;204:356-63.
90. Rypins EB, Mason GR, Conroy RM, Sarfeh IJ. Predictability and maintenance of portal flow patterns after small-diameter portacaval H-grafts in man. Ann Surg 1984;200:706-10.
91. Sarfeh IJ, Rypins EB, Conroy RM, Mason GR. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983;197: 422-6.
92. Rypins EB, Sarfeh IJ. Influence of portal hemodynamics on long-term survival of alcoholic cirrhotic patients after small-diameter portacaval H grafts. Am J Surg 1988;155:152-8.
93. Sarfeh IJ, Rypins EB, Fardi M, et al. Clinical implications of portal hemodynamics after small-diameter portacaval H graft. Surgery 1984;96:223-9.
94. Rypins EB, Milne N, Sarfeh IJ, Lyons KP. Quantitation and fractionation of nutrient hepatic blood flow in normal persons, in persons with portal hypertensive cirrhosis, and after small-diameter portacaval H grafts. Surgery 1988;104:335-42.
95. Rosemurgy AS II, Norman JG, Goode SE. Does the direction of portal blood flow determine outcome with small-diameter prosthetic H-graft portacaval shunt? Surgery 1997;121:95-101.
96. Rosemurgy AS, Goode SE, Zwiebel BR, et al. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996;224:378-84; discussion 384-6.
97. Rypins EB, Sarfeh IJ. Does portal pressure influence direction of portal flow and encephalopathy rates after 10-mm portacaval shunts in man? J Surg Res 1984;37: 119-22.
98. Godellas CV, Fabri PJ, Knierim TH, et al. Hepatic function after porto-systemic shunt. J Surg Res 1992;52:157-60.
99. Zervos EE, Goode SE, Rosemurgy AS. Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow. Am Surg 1998;64: 71-5 discussion 75-6.
100. Rypins EB, Milne N, Sarfeh IJ. Analysis of nutrient hepatic blood flow after 8-mm versus 16-mm portacaval H-grafts in a prospective randomized trial. Am J Surg 1995;169:197-200; discussion 200-1.
101. Rosemurgy AS II, Goode SE, Camps M. The effect of small-diameter H-graft portacaval shunts on portal blood flow. Am J Surg 1996;171:154-6; discussion 156-7.
102. Rosemurgy AS II, Bloomston M, Zervos EE, et al. Transjugular intrahepatic portosystemic shunt versus H-graft portacaval shunt in the management of bleeding varices: a cost-benefit analysis. Surgery 1997;122:794-9; discussion 799-800.
103. Rosemurgy AS, Serafini FM, Zervos EE, Goode SE. Small-diameter prosthetic H-graft portacaval shunt: definitive therapy for variceal bleeding. J Gastrointest Surg 1998;2:585-91.
104. Rosemurgy A. Small diameter interposition shunt. Mastery Surg 1998;3:1301-7.
105. Rosemurgy AS, McAllister EW, Godellas CV, et al. The effect of partial portal decompression on portal blood flow and effective hepatic blood flow in man: a prospective study. J Surg Res 1995;59:627-30.
106. Sarfeh IJ, Rypins EB. Partial shunting for portal hypertension: surgical technique. Contemp Surg 1988;32:11-6.
107. Rosemurgy AS, McAllister EW, Goode SE. Direction or reversal of preshunt portal blood flow as determinants of outcome up to 1 year after small-diameter prosthetic H-graft portacaval shunt. J Surg Res 1995;58:432-4.
108. Zervos EE, Goode SE, Rosemurgy AS. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt. J Surg Res 1998;74:71-5.
109. Rosemurgy AS, McAllister EW, Kurto HZ, Cates JD. Postprandial augmentation of portal hepatic inflow after prosthetic H-graft portacaval shunt. Am J Surg 1992; 163:213-5.
110. McAllister E, et al. Partial portal decompression alleviates thrombocytopenia of portal hypertension. Am Surg 1995;61:129-31.
111. Richter GM, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990;174:1027-30.
112. Zemel G, et al. Percutaneous transjugular portosystemic shunt. JAMA 1991;266: 390-3.
113. Conn HO. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology 1993;17:148-58.
114. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-71.
115. Kamath PS, McKusick MA. Transvenous intrahepatic portosystemic shunts. Gastroenterology 1996;111:1700-5.
116. Ralls PW, Egan RT, Katz MD, Teitelbaum GP. Color Doppler sonography to evaluate transjugular intrahepatic portacaval stent shunt. J Ultrasound Med 1993; 12:487-9.
117. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997;112:889-98.
118. Barton RE, Rosch J, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: Short and Long Term results: a survey of 1750 patients. Seminars in Interventional Radiology 1995;12:364-7.
119. LaBerge JM, Sombers KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-51.
120. Riggio O, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Dig Dis Sci 1996;41:578-84.
121. Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20:46-55.
122. Helton WS, Belshaw A, Althaus S, et al. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993;165:566-71.
123. Sanyal AJ, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111:138-46.
124. Helton WS, Maves R, Wicks K, Johansen K. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001;136:17-20.
125. Sanyal AJ, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial. Ann Intern Med 1997;126:849-57.
126. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043-9.
127. Cabrera J, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-9.
128. Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126:858-65.
129. Merli M, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998;27:48-53.
130. Sauer P, et al. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997;113:1623-31.
131. Garcia-Villarreal L, Martinez-Lagares F, Sierra A, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic selerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999;29:27-32.
132. Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26:1115-22.
133. Papatheodoridis GV, et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999;30:612-22.
134. Freeman RB Jr, FitzMaurice JE, Greenfield AE, et al. Is the transjugular intrahepatic portocaval shunt procedure beneficial for liver transplant recipients? Transplantation 1994;58:297-300.
135. Henderson JM, et al. Surgical shunts and TIPS for variceal decompression in the 1990s. Surgery 2000;128:540-7.
136. Khaitiyar JS, Luthra SK, Prasad N, et al. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt: a comparative study. Hepatogastroenterology 2000;47:492-7.
137. Rosemurgy AS, Serafini FM, Zweibel BR, et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000;4:589-97.
138. Rosemurgy AS, Zervos EE, Goode SE, et al. Differential effects on portal and effective hepatic blood flow. A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt. Ann Surg 1997;225:601-7; discussion 607-8.
139. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.
140. Orozco H, Mercado MA, Granados Garcia J, et al. Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg 1997;3:475-80.